Infections linked to wipes which may have been used to clean cuts
It comes after an outbreak of a bacteria, burkholderia stabilis (B. stabilis).
There have been 51 confirmed cases of B. stabilis between 2018 and 2025, with 'some serious infections which have required hospital treatment', the UK Health Security Agency (UKHSA) said.
Health chiefs said the outbreak is 'suspected to be associated with some non-sterile alcohol-free wipe products'.
UKHSA and the Medicines and Healthcare Products Regulatory Agency (MHRA) are advising people to stop using the products, which they may find in their at-home first aid kit, and to put them in the bin.
This includes: ValueAid Alcohol Free Cleansing Wipes; Microsafe Moist Wipe Alcohol Free and Steroplast Sterowipe Alcohol Free Cleansing Wipes.
Testing also found contamination of Reliwipe Alcohol Free Cleansing Wipes, though with a different strain of the bacteria linked to the outbreak.
While the warning only relates to the wipes listed, officials have reminded the public that non-sterile alcohol-free wipes should not be used for the treatment of wounds.
Dr James Elston, consultant in epidemiology at the UKHSA said: 'While the overall risk to the public remains very low, a number of non-sterile alcohol-free wipe products have been linked to an outbreak of Burkholderia stabilis.
'It is important these types of wipes are not used for the treatment of injuries, wounds, or broken skin, and that they are not used to clean intravenous lines.
'When treating cuts and grazes, it is important to follow NHS advice.'
Dr Alison Cave, MHRA's chief safety officer, added: 'We consider wipes which are intended for a medical purpose to be medicines. These products do not have a medicines authorisation, and we are taking appropriate action to ensure compliance with the requirements of the applicable legislation governed by MHRA.
'If you have these wipes at home or in a first aid kit, please check the label and only use wipes marked as 'sterile' on broken skin.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
14 minutes ago
- Glasgow Times
Respiratory Syncytial Virus: UK warning over rise in cases
Respiratory Syncytial Virus (RSV) is a common cause of coughs and colds, with most children getting an RSV infection at least once before they turn two years old. However, it can cause "serious breathing problems", and following a record number of RSV cases in Australia, the UK is being warned over a similar rise here. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. What is Respiratory Syncytial Virus? Respiratory Syncytial Virus (RSV) infections are described as "very common" by the NHS , but can cause serious illness in the elderly and young children. Despite typically being unserious, some babies and adults have a higher risk of getting seriously ill from RSV. The virus is a common cause of a type of chest infection called bronchiolitis in babies, which can cause breathing problems and may need to be treated in hospital. There is a vaccine for RSV, which, as the NHS explains, is recommended if: You're pregnant (from 28 weeks of pregnancy) – this will help protect your baby for the first few months after they're born You're aged 75 to 79 Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It was revealed that the jab for pregnant women can prevent 72% of hospital admissions for their babies. Meanwhile, the UKHSA said the vaccine is 82% effective at preventing hospital admissions for RSV among older adults. Symptoms of an RSV infection The NHS says symptoms of an RSV infection typically start within a few days of getting infected. Most people only get cold-like symptoms, such as: a runny or blocked nose a cough sneezing tiredness a high temperature – signs include your back or chest feeling hotter than usual, sweatiness and shivering (chills) It says that babies with RSV may also be irritable and feed less than usual. What is RSV? 💭 It's a respiratory virus that can cause serious illness in the elderly & young children. If a woman has the vaccination during pregnancy, it cuts the risk of serious lung infection caused by #RSV in her baby's first 6 months Read more: — UK Health Security Agency (@UKHSA) August 4, 2025 However, if the virus leads to a more serious infection (such as pneumonia or bronchiolitis), it may also cause: a cough that gets worse shortness of breath faster breathing or long gaps between breaths difficulty feeding (in babies) or loss of appetite noisy breathing (wheezing) confusion (in older adults) Warning to UK over rise in RSV cases Health experts have warned that the UK should brace for a surge in RSV following a record number of cases in Australia. Officials have said that cases have been steadily increasing in England since the start of 2025, and NHS England has urged pregnant women to get the vaccine to protect newborn babies. It said that the virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Recommended reading: Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab. NHS England will start inviting people to come forward in the next few weeks.
Daily Record
39 minutes ago
- Daily Record
NHS warns serious virus 'rampant in Australia' is coming to UK as cases surge
The NHS has warned that people should be on the lookout for a serious virus with the most vulnerable getting vaccinations Britain should prepare for a spike in a potentially dangerous virus after Australia recorded unprecedented case numbers, health experts have warned. NHS bosses said that Australia's winter season often serves as a reliable indicator of how viruses will behave in England. Following a dramatic rise in respiratory syncytial virus (RSV) infections across Australia, officials have confirmed that case numbers have been climbing steadily in England since early 2025. NHS England has called on expectant mothers to receive the RSV jab to shield their newborn infants from the illness. Health chiefs said the virus ranks as a top killer of babies and represents the primary reason children end up in hospital. Kate Brintworth, chief midwifery officer for NHS England, said: "While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. "Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating." Expectant mothers can receive the vaccination from 28 weeks into their pregnancy via maternity services or their local GP practice. Adults aged between 75 and 79 also qualify for the injection, with NHS England set to begin sending out invitations over the coming weeks. RSV is a frequent culprit behind coughs and colds. However, certain individuals, such as infants and those over 75, are at a heightened risk of severe illness from the virus. In babies, RSV often leads to a chest infection known as bronchiolitis. The UK Health Security Agency recently released data demonstrating the vaccine's effectiveness. According to their findings, the jab for expectant mothers can prevent 72% of hospital admissions for their newborns. Furthermore, the vaccine is 82% effective in preventing hospital admissions due to RSV among the elderly, as per the UKHSA.
Daily Mirror
3 hours ago
- Daily Mirror
NHS warns serious virus 'rampant in Australia' coming to UK
NHS England is urging people to get the vaccine for illness which 'can lead to serious breathing problems that can end up in hospitalisation' The UK should brace for a surge in a potentially serious virus following a record number of cases in Australia, health experts have said. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. And following a surge in cases number of respiratory syncytial virus (RSV) cases in Australia, officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the vaccine which protects against RSV in order to protect their newborn babies. It said that the virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab and NHS England will start inviting people to come forward in the next few weeks. RSV is a common cause of coughs and colds. But some people have a high risk of getting seriously ill from the virus including babies and adults over the age of 75. In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab for pregnant women can prevent 72% of hospital admissions for their babies. And the vaccine is 82% effective at preventing hospital admissions for RSV among older adults, UKHSA said.
